Corrigendum to “Immune-checkpoint inhibition in first-line treatment of advanced non-small cell lung cancer patients: Current status and future approaches” [Lung Cancer 106 (2017) 70–75]
| Autor: | Remon, J., Pardo, N., Martinez-Martí, A., Cedrés, S., Navarro, A., Martinez de Castro, A.M., Felip, E. |
|---|---|
| Zdroj: | In Lung Cancer March 2018 117:80-80 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect